Literature DB >> 3582471

Acute haemodynamic and humoral responses to felodipine and metoprolol in mild hypertension.

R Fagard, P Lijnen, E Moerman, J Staessen, A Amery.   

Abstract

Oral administration of felodipine to 10 patients with mild essential hypertension acutely reduced systemic vascular resistance (SVR) by 40% after 30 min. The change in SVR was significantly related to age (r = -0.74). The reduction in the intraarterially measured brachial artery pressure was limited to 15/13 mmHg, due to a rise in cardiac output (CO). The tachycardia was sustained for 90 min, as was an elevation of plasma noradrenaline. There was a transient increase in stroke volume, associated with a reduction in pulmonary capillary wedge pressure, which was at least partly due to a reduced intravascular volume. In contrast to SVR, pulmonary vascular resistance was not affected by felodipine. Addition of intravascular metoprolol after 90 min decreased HR and CO and augmented SVR. The felodipine-induced rise in plasma renin activity (PRA) of 100% was completely reversed by metoprolol. Plasma angiotensin II (PA II) rose by 15% during felodipine, whereas plasma aldosterone concentration (PAC) was not affected. Thus, acutely administered felodipine was a potent dilator of systemic but not of pulmonary arterioles, it stimulated the sympathetic nervous system, and reduced left ventricular filling pressure. The rise in plasma renin did not result in a higher plasma aldosterone level, due partly to reduced generation of angiotensin II.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3582471     DOI: 10.1007/bf00609960

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Effect of age and high blood pressure on baroreflex sensitivity in man.

Authors:  B Gribbin; T G Pickering; P Sleight; R Peto
Journal:  Circ Res       Date:  1971-10       Impact factor: 17.367

2.  Quantitation of catecholamines in urine and in plasma.

Authors:  E J Moerman; A F De Schaepdryver
Journal:  Clin Chim Acta       Date:  1984-06-13       Impact factor: 3.786

3.  Response of the systemic and pulmonary circulation to alpha- and beta-receptor blockade (labetalol) at rest and during exercise in hypertensive patients.

Authors:  R Fagard; A Amery; T Reybrouck; P Lijnen; L Billiet
Journal:  Circulation       Date:  1979-12       Impact factor: 29.690

4.  Direct radioimmunoassay of plasma aldosterone in normal subjects.

Authors:  P Lijnen; A Amery; R Fagard; P Corvol
Journal:  Clin Chim Acta       Date:  1978-03-15       Impact factor: 3.786

5.  Faster radioimmunoassay of angiotensin I at 37 degrees C.

Authors:  F Fyhrquist; L Puutula
Journal:  Clin Chem       Date:  1978-01       Impact factor: 8.327

6.  Felodipine in primary pulmonary hypertension. Report of two cases.

Authors:  K Arnman; L Rydén; P Smedgård; E Thorhallsson
Journal:  Acta Med Scand       Date:  1984

7.  Renal and cardiovascular effects of acute and chronic administration of felodipine to SHR.

Authors:  M Nordlander; G F Di Bona; B Ljung; T Yao; P Thorén
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

8.  Effect of nifedipine on blood pressure and adrenocortical responses to trophic stimuli in humans.

Authors:  J A Millar; A D Struthers; G H Beastall; J L Reid
Journal:  J Cardiovasc Pharmacol       Date:  1982       Impact factor: 3.105

9.  The place of the calcium antagonist verapamil in antihypertensive therapy.

Authors:  F R Bühler; U L Hulthén; W Kiowski; F B Müller; P Bolli
Journal:  J Cardiovasc Pharmacol       Date:  1982       Impact factor: 3.105

10.  Felodipine. A calcium-inhibiting vasodilator in refractory hypertension.

Authors:  O K Andersson; G Granérus; T Hedner
Journal:  Drugs       Date:  1985       Impact factor: 9.546

View more
  10 in total

1.  Evaluation of three methods of symptom reporting in a clinical trial of felodipine.

Authors:  M A Wallander; E Dimenäs; K Svärdsudd; I Wiklund
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Pharmacokinetics and blood pressure effects of felodipine in elderly hypertensive patients. A comparison with young healthy subjects.

Authors:  S Landahl; B Edgar; M Gabrielsson; M Larsson; B Lernfelt; P Lundborg; C G Regårdh
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

Review 3.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  E Saltiel; A G Ellrodt; J P Monk; M S Langley
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

4.  Felodipine in combination with a beta-adrenoceptor blocker as an effective substitute for triple therapy in severe hypertension. The Australian Felodipine Multicentre Study Group.

Authors:  D B Frewin; P Aldons; L L Wilson; E F O'Sullivan; R N Wyndham; J Karrasch; J Agar; B B Singh; B Jackson; P F Atkins
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 5.  The treatment of heart failure--what next?

Authors:  R H Davies; D J Sheridan
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

6.  Effects of felodipine and metoprolol on blood pressure, plasma renin, angiotensin II, aldosterone and catecholamines in hypertensive patients.

Authors:  P Lijnen; R Fagard; J Staessen; E Moerman; A De Schaepdryver; A Amery
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 7.  Felodipine/metoprolol: a review of the fixed dose controlled release formulation in the management of essential hypertension.

Authors:  M Haria; G L Plosker; A Markham
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

8.  Adverse event monitoring in clinical trials of felodipine and omeprazole.

Authors:  M A Wallander; P Lundborg; K Svärdsudd
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

9.  Acute calcium entry blockade inhibits the blood pressure but not the hormonal responses to angiotensin II.

Authors:  J Staessen; R Fagard; P Hespel; P Lijnen; E Moerman; A Amery
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

10.  Felodipine in severe chronic congestive heart failure: acute effects on central hemodynamics and regional blood flow distribution.

Authors:  G Binetti; I Rubino; E Varani; R Spadoni; R M Ferretti; V Cervi; B Magnani
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.